JNJJohnson & Johnson

Health care · Pharmaceuticals · NYSE

JNJ and 9 peers, year by year

The 9 Health care companies closest to JNJ in revenue over the last twelve months. Every number is from the 10-K and links to it in SEC's Inline XBRL viewer.

5 years 10 years Download CSV

Choose the peers

Each company's latest fiscal year
Company	Year	Revenue	Sales growth	Gross margin	Operating margin	Net margin	FCF margin	Return on equity	Debt / equity
JNJ Johnson & Johnson	FY2025	$94.2B	+6.0%	67.9%	-	28.5%	20.9%	32.9%	0.61
LLY Eli Lilly	FY2025	$65.2B	+44.7%	-	-	31.7%	-	77.8%	1.54
HCA HCA Healthcare	FY2025	$75.6B	+7.1%	-	-	9.0%	10.2%	n/m	n/m
MRK Merck & Co.	FY2025	$65.0B	+1.3%	-	-	28.1%	19.0%	34.7%	0.94
ABBV AbbVie	FY2025	$61.2B	+8.6%	-	24.6%	6.9%	29.1%	n/m	n/m
PFE Pfizer	FY2025	$62.6B	−1.6%	-	-	12.4%	14.5%	9.0%	0.75
BMY Bristol Myers Squibb	FY2025	$48.2B	−0.2%	-	-	14.6%	26.7%	38.2%	2.55
ABT Abbott Laboratories	FY2025	$44.3B	+5.7%	-	18.2%	14.7%	16.7%	12.5%	0.25
TMO Thermo Fisher Scientific	FY2025	$44.6B	+3.9%	-	17.4%	15.0%	14.1%	12.6%	0.80
HUM Humana	FY2025	$129.7B	+10.1%	-	2.1%	0.9%	0.3%	6.7%	0.70

Revenuepeer median $62.6B

Sales growthpeer median +5.7%

Operating marginpeer median 17.8%

ABBV 24.6%
ABT 18.2%
TMO 17.4%
HUM 2.1%
JNJ -
LLY -
HCA -
MRK -
PFE -
BMY -

Net marginpeer median 14.6%

FCF marginpeer median 15.6%

Return on equitypeer median 12.6%

Debt / equitypeer median 0.80

BMY 2.55
LLY 1.54
MRK 0.94
TMO 0.80
PFE 0.75
HUM 0.70
JNJ 0.61
ABT 0.25
HCA n/m
ABBV n/m

RevenueSales growthGross marginOperating marginNet marginFree cash flowFCF marginReturn on equityDebt / equityEPS (diluted)

Revenue, FY2015 to FY2025

Revenue as reported in the 10-K.

Company	FY2015	FY2016	FY2017	FY2018	FY2019	FY2021	FY2022	FY2023	FY2024	FY2025
JNJ Dec	-	$71.9B	$76.5B	$81.6B	$82.1B	$78.7B	$80.0B	$85.2B	$88.8B	$94.2B
LLY Dec	$20.0B	$21.2B	$20.0B	$21.5B	$22.3B	$28.3B	$28.5B	$34.1B	$45.0B	$65.2B
HCA Dec	-	$41.5B	$43.6B	$46.7B	$51.3B	$58.8B	$60.2B	$65.0B	$70.6B	$75.6B
MRK Dec	-	$39.8B	$40.1B	$42.3B	$39.1B	$48.7B	$59.3B	$60.1B	$64.2B	$65.0B
ABBV Dec	$22.9B	$25.6B	$28.2B	$32.8B	$33.3B	$56.2B	$58.1B	$54.3B	$56.3B	$61.2B
PFE Dec	-	$52.8B	$52.5B	$40.8B	$40.9B	$81.3B	$101.2B	$59.6B	$63.6B	$62.6B
BMY Dec	$16.6B	$19.4B	$20.8B	$22.6B	$26.1B	$46.4B	$46.2B	$45.0B	$48.3B	$48.2B
ABT Dec	$20.4B	$20.9B	$27.4B	$30.6B	$31.9B	$43.1B	$43.7B	$40.1B	$42.0B	$44.3B
TMO Dec	$17.0B	$18.3B	$20.9B	$24.4B	$25.5B	$39.2B	$44.9B	$42.9B	$42.9B	$44.6B
HUM Dec	$54.3B	$54.4B	$53.8B	$56.9B	$64.9B	$83.1B	$92.9B	$106.4B	$117.8B	$129.7B
Peer median	$20.2B	$25.6B	$28.2B	$32.8B	$33.3B	$48.7B	$58.1B	$54.3B	$56.3B	$62.6B

Sales growth, FY2015 to FY2025

Revenue against the fiscal year before.

Company	FY2015	FY2016	FY2017	FY2018	FY2019	FY2021	FY2022	FY2023	FY2024	FY2025
JNJ Dec	-	-	+6.3%	+6.7%	+0.6%	+13.6%	+1.6%	+6.5%	+4.3%	+6.0%
LLY Dec	-	+6.3%	+7.8%	+7.6%	+3.8%	+15.4%	+0.8%	+19.6%	+32.0%	+44.7%
HCA Dec	-	-	+5.1%	+7.0%	+10.0%	+14.0%	+2.5%	+7.9%	+8.7%	+7.1%
MRK Dec	-	-	+0.8%	+5.4%	+10.7%	+17.3%	+21.7%	+1.4%	+6.7%	+1.3%
ABBV Dec	-	+12.2%	+10.1%	+16.1%	+1.6%	+22.7%	+3.3%	−6.4%	+3.7%	+8.6%
PFE Dec	-	-	−0.5%	+2.1%	+0.8%	+95.2%	+24.7%	−41.1%	+6.8%	−1.6%
BMY Dec	-	+17.3%	+6.9%	+8.6%	+15.9%	+9.1%	−0.5%	−2.5%	+7.3%	−0.2%
ABT Dec	-	+2.2%	+31.3%	+11.6%	+4.3%	+24.5%	+1.3%	−8.1%	+4.6%	+5.7%
TMO Dec	-	+7.7%	+14.5%	+16.4%	+4.9%	+21.7%	+14.5%	−4.6%	+0.1%	+3.9%
HUM Dec	-	+0.2%	−1.1%	+5.8%	+14.0%	+7.7%	+11.8%	+14.5%	+10.7%	+10.1%
Peer median	-	+7.0%	+6.9%	+7.6%	+4.9%	+17.3%	+3.3%	−2.5%	+6.8%	+5.7%

Gross margin, FY2015 to FY2025

Gross profit / revenue.

Company	FY2015	FY2016	FY2017	FY2018	FY2019	FY2021	FY2022	FY2023	FY2024	FY2025
JNJ Dec	-	69.7%	66.7%	66.8%	66.4%	70.3%	69.3%	68.8%	69.1%	67.9%
LLY Dec	-	-	-	-	-	-	-	-	-	-
HCA Dec	-	-	-	-	-	-	-	-	-	-
MRK Dec	-	-	-	-	-	-	-	-	-	-
ABBV Dec	-	-	-	-	-	-	-	-	-	-
PFE Dec	-	-	-	-	-	-	-	-	-	-
BMY Dec	76.4%	74.5%	70.7%	71.3%	69.1%	-	-	-	-	-
ABT Dec	-	-	-	-	-	-	-	-	-	-
TMO Dec	-	-	-	-	-	-	-	-	-	-
HUM Dec	-	-	-	-	-	-	-	-	-	-
Peer median	-	-	-	-	-	-	-	-	-	-

Operating margin, FY2015 to FY2025

Operating income / revenue.

Company	FY2015	FY2016	FY2017	FY2018	FY2019	FY2021	FY2022	FY2023	FY2024	FY2025
JNJ Dec	-	-	-	-	-	-	-	-	-	-
LLY Dec	-	-	-	-	-	-	-	-	-	-
HCA Dec	-	-	-	-	-	-	-	-	-	-
MRK Dec	-	-	-	-	-	-	-	-	-	-
ABBV Dec	33.0%	36.4%	33.8%	19.5%	39.0%	31.9%	31.2%	23.5%	16.2%	24.6%
PFE Dec	-	-	-	-	-	-	-	-	-	-
BMY Dec	-	-	-	-	-	-	-	-	-	-
ABT Dec	14.1%	14.5%	5.7%	11.9%	14.2%	19.6%	19.2%	16.2%	16.3%	18.2%
TMO Dec	13.8%	13.5%	14.2%	15.5%	18.0%	25.6%	18.7%	16.0%	17.1%	17.4%
HUM Dec	4.3%	3.2%	7.9%	5.4%	4.9%	3.8%	4.1%	3.8%	2.2%	2.1%
Peer median	13.9%	14.0%	11.0%	13.7%	16.1%	22.6%	18.9%	16.1%	16.2%	17.8%

Net margin, FY2015 to FY2025

Net income / revenue.

Company	FY2015	FY2016	FY2017	FY2018	FY2019	FY2021	FY2022	FY2023	FY2024	FY2025
JNJ Dec	-	23.0%	1.7%	18.8%	18.4%	26.5%	22.4%	41.3%	15.8%	28.5%
LLY Dec	12.1%	12.9%	−1.0%	15.0%	37.3%	19.7%	21.9%	15.4%	23.5%	31.7%
HCA Dec	-	7.0%	5.1%	8.1%	6.8%	11.8%	9.4%	8.1%	8.2%	9.0%
MRK Dec	-	9.8%	6.0%	14.7%	25.2%	26.8%	24.5%	0.6%	26.7%	28.1%
ABBV Dec	22.5%	23.2%	18.8%	17.4%	23.7%	20.5%	20.4%	9.0%	7.6%	6.9%
PFE Dec	-	13.7%	40.6%	27.3%	39.2%	27.0%	31.0%	3.6%	12.6%	12.4%
BMY Dec	9.5%	22.9%	4.8%	21.8%	13.2%	15.1%	13.7%	17.8%	−18.5%	14.6%
ABT Dec	21.7%	6.7%	1.7%	7.7%	11.6%	16.4%	15.9%	14.3%	31.9%	14.7%
TMO Dec	11.6%	11.1%	10.6%	12.1%	14.5%	19.7%	15.5%	14.0%	14.8%	15.0%
HUM Dec	2.4%	1.1%	4.6%	3.0%	4.2%	3.5%	3.0%	2.3%	1.0%	0.9%
Peer median	11.9%	11.1%	5.1%	14.7%	14.5%	19.7%	15.9%	9.0%	12.6%	14.6%

Free cash flow, FY2015 to FY2025

Cash from operations minus capital spending.

Company	FY2015	FY2016	FY2017	FY2018	FY2019	FY2021	FY2022	FY2023	FY2024	FY2025
JNJ Dec	$16.1B	$15.5B	$17.8B	$18.5B	$19.9B	$19.8B	$17.2B	$18.2B	$19.8B	$19.7B
LLY Dec	-	-	-	-	-	-	-	-	-	-
HCA Dec	$2.4B	$2.9B	$2.4B	$3.2B	$3.4B	$5.4B	$4.1B	$4.7B	$5.6B	$7.7B
MRK Dec	$11.3B	$8.8B	$4.6B	$8.3B	$10.1B	$8.7B	$14.7B	$9.1B	$18.1B	$12.4B
ABBV Dec	$7.0B	$6.6B	$9.4B	$12.8B	$12.8B	$22.0B	$24.2B	$22.1B	$17.8B	$17.8B
PFE Dec	$13.3B	$14.4B	$14.8B	$13.8B	$10.5B	$29.9B	$26.0B	$4.8B	$9.8B	$9.1B
BMY Dec	$1.3B	$1.8B	$4.2B	$6.1B	$7.4B	$15.2B	$11.9B	$12.7B	$13.9B	$12.8B
ABT Dec	$1.9B	$2.1B	$4.4B	$4.9B	$4.5B	$8.6B	$7.8B	$5.1B	$6.4B	$7.4B
TMO Dec	$2.5B	$2.8B	$3.5B	$3.8B	$4.0B	$6.8B	$6.9B	$6.9B	$7.3B	$6.3B
HUM Dec	$345.0M	$1.4B	$3.5B	$1.6B	$4.5B	$920.0M	$3.5B	$3.0B	$2.4B	$375.0M
Peer median	$2.4B	$2.9B	$4.3B	$5.5B	$6.0B	$8.7B	$9.9B	$6.0B	$8.6B	$8.4B

FCF margin, FY2015 to FY2025

Free cash flow / revenue.

Company	FY2015	FY2016	FY2017	FY2018	FY2019	FY2021	FY2022	FY2023	FY2024	FY2025
JNJ Dec	-	21.6%	23.3%	22.7%	24.3%	25.1%	21.5%	21.4%	22.3%	20.9%
LLY Dec	-	-	-	-	-	-	-	-	-	-
HCA Dec	-	7.0%	5.5%	6.8%	6.7%	9.2%	6.9%	7.2%	8.0%	10.2%
MRK Dec	-	22.0%	11.4%	19.6%	25.7%	17.8%	24.8%	15.2%	28.2%	19.0%
ABBV Dec	30.6%	25.6%	33.4%	39.0%	38.4%	39.1%	41.8%	40.6%	31.7%	29.1%
PFE Dec	-	27.2%	28.3%	33.9%	25.8%	36.7%	25.7%	8.0%	15.5%	14.5%
BMY Dec	7.8%	9.5%	20.3%	27.1%	28.2%	32.8%	25.9%	28.1%	28.9%	26.7%
ABT Dec	9.1%	10.0%	16.2%	16.0%	14.1%	20.1%	17.9%	12.6%	15.1%	16.7%
TMO Dec	14.8%	15.4%	16.7%	15.5%	15.8%	17.3%	15.4%	16.2%	16.9%	14.1%
HUM Dec	0.6%	2.6%	6.6%	2.7%	7.0%	1.1%	3.7%	2.8%	2.0%	0.3%
Peer median	9.1%	12.7%	16.5%	17.8%	20.8%	18.9%	21.3%	13.9%	16.2%	15.6%

Return on equity, FY2015 to FY2025

Net income / shareholders' equity at the year end.

Company	FY2015	FY2016	FY2017	FY2018	FY2019	FY2021	FY2022	FY2023	FY2024	FY2025
JNJ Dec	21.7%	23.5%	2.2%	25.6%	25.4%	28.2%	23.4%	51.1%	19.7%	32.9%
LLY Dec	16.5%	19.5%	−1.8%	32.9%	n/m	62.2%	58.6%	48.6%	74.2%	77.8%
HCA Dec	n/m	n/m	n/m	n/m	n/m	n/m	n/m	n/m	n/m	n/m
MRK Dec	9.9%	9.8%	7.0%	23.3%	38.0%	34.2%	31.6%	1.0%	37.0%	34.7%
ABBV Dec	130.4%	128.4%	104.2%	n/m	n/m	74.9%	68.6%	46.9%	128.7%	n/m
PFE Dec	10.8%	12.1%	29.9%	17.6%	25.4%	28.5%	32.8%	2.4%	9.1%	9.0%
BMY Dec	11.0%	27.6%	8.6%	35.1%	6.7%	19.5%	20.4%	27.3%	−54.8%	38.2%
ABT Dec	20.9%	6.8%	1.5%	7.8%	11.9%	19.8%	18.9%	14.8%	28.1%	12.5%
TMO Dec	9.3%	9.4%	8.8%	10.7%	12.5%	18.9%	15.8%	12.8%	12.8%	12.6%
HUM Dec	12.3%	5.7%	24.9%	16.6%	22.5%	18.2%	18.3%	15.3%	7.4%	6.7%
Peer median	11.7%	10.9%	8.7%	17.6%	17.5%	24.1%	26.0%	15.1%	20.4%	12.6%

Debt / equity, FY2015 to FY2025

Total debt / shareholders' equity at the year end.

Company	FY2015	FY2016	FY2017	FY2018	FY2019	FY2021	FY2022	FY2023	FY2024	FY2025
JNJ Dec	0.28	0.41	0.60	0.55	0.47	0.48	0.54	0.45	0.54	0.61
LLY Dec	0.55	0.74	1.09	0.99	5.80	1.86	1.53	2.35	2.37	1.54
HCA Dec	n/m	n/m	n/m	n/m	n/m	n/m	n/m	n/m	n/m	n/m
MRK Dec	0.59	0.62	0.71	0.94	1.02	0.87	0.67	0.93	0.80	0.94
ABBV Dec	8.03	7.95	7.33	n/m	n/m	4.93	3.66	5.72	n/m	n/m
PFE Dec	0.54	0.62	0.61	0.64	0.81	0.49	0.37	0.81	0.72	0.75
BMY Dec	0.47	0.41	0.62	0.49	0.96	1.37	1.39	1.34	3.15	2.55
ABT Dec	0.42	1.07	0.90	0.64	0.58	0.50	0.46	0.38	0.30	0.25
TMO Dec	0.54	0.76	0.78	0.71	0.62	0.91	0.91	0.82	0.67	0.80
HUM Dec	0.40	0.38	0.50	0.60	0.47	0.78	0.73	0.72	0.72	0.70
Peer median	0.54	0.68	0.75	0.64	0.81	0.89	0.82	0.88	0.72	0.80

EPS (diluted), FY2015 to FY2025

Diluted earnings per share, on today's share count after splits.

Company	FY2015	FY2016	FY2017	FY2018	FY2019	FY2021	FY2022	FY2023	FY2024	FY2025
JNJ Dec	$5.48	$5.93	$0.47	$5.61	$5.63	$7.81	$6.73	$13.72	$5.79	$11.03
LLY Dec	$2.26	$2.58	−$0.19	$3.13	$8.89	$6.12	$6.90	$5.80	$11.71	$22.95
HCA Dec	$4.99	$7.30	$5.95	$10.66	$10.07	$21.16	$19.15	$18.97	$22.00	$28.33
MRK Dec	$1.56	$1.41	$0.87	$2.32	$3.81	$5.14	$5.71	$0.14	$6.74	$7.28
ABBV Dec	$3.13	$3.63	$3.30	$3.66	$5.28	$6.45	$6.63	$2.72	$2.39	$2.36
PFE Dec	$1.11	$1.17	$3.52	$1.87	$2.82	$3.85	$5.47	$0.37	$1.41	$1.36
BMY Dec	$0.93	$2.65	$0.61	$3.01	$2.01	$3.12	$2.95	$3.86	−$4.41	$3.46
ABT Dec	$2.92	$0.94	$0.27	$1.33	$2.06	$3.94	$3.91	$3.26	$7.64	$3.72
TMO Dec	$4.92	$5.09	$5.59	$7.24	$9.17	$19.46	$17.63	$15.45	$16.53	$17.74
HUM Dec	$8.44	$4.07	$16.81	$12.16	$20.10	$22.67	$22.08	$20.00	$9.98	$9.84
Peer median	$2.92	$2.65	$3.30	$3.13	$5.28	$6.12	$6.63	$3.86	$7.64	$7.28

Fiscal years are lined up as each company's 10-K names them; the month next to a ticker is when its year ends. Hover a number for the XBRL line items and the filing; click it to open the filing on sec.gov. "n/m" means not meaningful: equity below zero, or a base so close to zero that the ratio says nothing. The peer median leaves out JNJ and needs at least three peers with the number. P/E, P/S and P/FCF at each year end appear here once the site has daily prices. What the same companies write about AI, tariffs and more →

Next Industry numbers →

Work on JNJ in a spreadsheet: Excel workbook (a sheet per section, ten years by column, charts, links to the filings) · CSV. For a Google Sheet that stays up to date, paste =IMPORTDATA("https://tickdelta.com/company/JNJ/export.csv") into a cell.